Scholars@Duke
Journal cover image

Comment on 'Patient-reported outcomes and the patient experience of acute myeloid leukemia among older adults'.

Publication ,  Journal Article
Pisarcik, MJ; LeBlanc, TW
Published in: J Geriatr Oncol
September 2022
Published version (DOI) Link to item

Duke Scholars

Matthew Pisarcik
Author Matthew Pisarcik  
Thomas William LeBlanc
Author Thomas William LeBlanc Medicine, Hematologic Malignancies and Cellular Therapy
Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Geriatr Oncol

DOI

10.1016/j.jgo.2022.06.005

EISSN

1879-4076

Publication Date

September 2022

Volume

13

Issue

7

Start / End Page

940 / 942

Location

Netherlands

Related Subject Headings

  • Patient Reported Outcome Measures
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
  • Humans
  • Aged
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Pisarcik, M. J., & LeBlanc, T. W. (2022). Comment on 'Patient-reported outcomes and the patient experience of acute myeloid leukemia among older adults'. J Geriatr Oncol, 13(7), 940–942. https://doi.org/10.1016/j.jgo.2022.06.005
Pisarcik, Matthew J., and Thomas W. LeBlanc. “Comment on 'Patient-reported outcomes and the patient experience of acute myeloid leukemia among older adults'.” J Geriatr Oncol 13, no. 7 (September 2022): 940–42. https://doi.org/10.1016/j.jgo.2022.06.005.
Pisarcik, Matthew J., and Thomas W. LeBlanc. “Comment on 'Patient-reported outcomes and the patient experience of acute myeloid leukemia among older adults'.” J Geriatr Oncol, vol. 13, no. 7, Sept. 2022, pp. 940–42. Pubmed, doi:10.1016/j.jgo.2022.06.005.
Journal cover image

Published In

J Geriatr Oncol

DOI

10.1016/j.jgo.2022.06.005

EISSN

1879-4076

Publication Date

September 2022

Volume

13

Issue

7

Start / End Page

940 / 942

Location

Netherlands

Related Subject Headings

  • Patient Reported Outcome Measures
  • Myelodysplastic Syndromes
  • Leukemia, Myeloid, Acute
  • Humans
  • Aged
  • 3211 Oncology and carcinogenesis
  • 1112 Oncology and Carcinogenesis